← Back
Data updated: Mar 29, 2026
I 3 PHARMS
ImmunologyInfectious DiseaseCardiovascular
Generics
I 3 PHARMS is a generic drug manufacturer focused on Immunology, Infectious Disease, Cardiovascular.
2023
Since
4
Drugs
-
Trials
30
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 33%
1 drugs
Infectious Disease 33%
1 drugs
Cardiovascular 33%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
Merck big-pharma
Infectious Disease, Cardiovascular, Immunology
Johnson & Johnson big-pharma
Immunology, Infectious Disease, Cardiovascular
COSETTE other
Cardiovascular, Infectious Disease, Immunology
BAUSCH AND LOMB specialty
Cardiovascular, Infectious Disease, Immunology
Pfizer big-pharma
Infectious Disease, Immunology
Discontinued (0)
Company Info
- First Approval
- 2023-08-17
- Latest
- 2026-01-26
- Applications
- 4